|
1
|
Blesch A and Tuszynski MH: Spontaneous and
neurotrophin-induced axonal plasticity after spinal cord injury.
Prog Brain Res. 137:415–423. 2002.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Iarikov DE, Kim BG, Dai HN, McAtee M, Kuhn
PL and Bregman BS: Delayed transplantation with exogenous
neurotrophin administration enhances plasticity of corticofugal
projections after spinal cord injury. J Neurotrauma. 24:690–702.
2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Benussi L, Binetti G and Ghidoni R: Loss
of neuroprotective factors in neurodegenerative dementias: The end
or the starting point? Front Neurosci. 11(672)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Palasz E, Wysocka A, Gasiorowska A,
Chalimoniuk M, Niewiadomski W and Niewiadomska G: BDNF as a
promising therapeutic agent in Parkinson's disease. Int J Mol Sci.
21(1170)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ziemssen T, Kümpfel T, Schneider H,
Klinkert WE, Neuhaus O and Hohlfeld R: Secretion of brain-derived
neurotrophic factor by glatiramer acetate-reactive T-helper cell
lines: Implications for multiple sclerosis therapy. J Neurol Sci.
233:109–112. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nakahashi T, Fujimura H, Altar CA, Li J,
Kambayashi J, Tandon NN and Sun B: Vascular endothelial cells
synthesize and secrete brain-derived neurotrophic factor. FEBS
Lett. 470:113–117. 2000.PubMed/NCBI View Article : Google Scholar
|
|
7
|
D'Onofrio M, de Grazia U, Morrone S, Cuomo
L, Spinsanti P, Frati L, Gulino A and Ragona G: Expression of
neurotrophin receptors in normal and malignant B lymphocytes. Eur
Cytokine Netw. 11:283–291. 2000.PubMed/NCBI
|
|
8
|
Skaper SD: The biology of neurotrophins,
signalling pathways, and functional peptide mimetics of
neurotrophins and their receptors. CNS Neurol Disord Drug Targets.
7:46–62. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tian B, Yang C, Wang J, Hou X, Zhao S, Li
Y and Yang P: Peripheral blood brain-derived neurotrophic factor
level and tyrosine kinase B expression on T lymphocytes in systemic
lupus erythematosus: Implications for systemic involvement.
Cytokine. 123(154764)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lühder F, Gold R, Flügel A and Linker RA:
Brain-derived neurotrophic factor in neuroimmunology: Lessons
learned from multiple sclerosis patients and experimental
autoimmune encephalomyelitis models. Arch Immunol Ther Exp (Warsz).
61:95–105. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hu ZL, Luo C, Hurtado PR, Li H, Wang S, Hu
B, Xu JM, Liu Y, Feng SQ, Hurtado-Perez E, et al: Brain-derived
neurotrophic factor precursor in the immune system is a novel
target for treating multiple sclerosis. Theranostics. 11:715–730.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kleczynska W, Jakiela B, Plutecka H,
Milewski M, Sanak M and Musial J: Imbalance between Th17 and
regulatory T-cells in systemic lupus erythematosus. Folia Histochem
Cytobiol. 49:646–653. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yoshio T, Okamoto H, Kurasawa K, Dei Y,
Hirohata S and Minota S: IL-6, IL-8, IP-10, MCP-1 and G-CSF are
significantly increased in cerebrospinal fluid but not in sera of
patients with central neuropsychiatric lupus erythematosus. Lupus.
25:997–1003. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kawai T and Akira S: Toll-like receptors
and their crosstalk with other innate receptors in infection and
immunity. Immunity. 34:637–650. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen Y, Zeng J, Cen L, Chen Y, Wang X, Yao
G, Wang W, Qi W and Kong K: Multiple roles of the p75 neurotrophin
receptor in the nervous system. J Intl Med Res. 37:281–288.
2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Blöchl A and Blöchl R: A cell-biological
model of p75NTR signaling. J Neurochem. 102:289–305.
2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gao C, Zhang L, Sun D, Li J, Yao X, Zhou H
and Wang Y: Roles of p75NTR in maintaining brain hemostasis and the
implications for p75NTR-targeted Therapies. Curr Alzheimer Res.
14:554–561. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Deinhardt K and Chao MV: Trk receptors.
Handb Exp Pharmacol. 220:103–119. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Meier S, Alfonsi F, Kurniawan ND, Milne
MR, Kasherman MA, Delogu A, Piper M and Coulson EJ: The p75
neurotrophin receptor is required for the survival of neuronal
progenitors and normal formation of the basal forebrain, striatum,
thalamus and neocortex. Development. 146(dev181933)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Roux PP and Barker PA: Neurotrophin
signaling through the p75 neurotrophin receptor. Prog Neurobiol.
67:203–233. 2002.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kendall SE, Goldhawk DE, Kubu C, Barker PA
and Verdi JM: Expression analysis of a novel p75(NTR) signaling
protein, which regulates cell cycle progression and apoptosis. Mech
Dev. 117:187–200. 2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Enomoto M, Bunge MB and Tsoulfas P: A
multifunctional neurotrophin with reduced affinity to p75NTR
enhances transplanted Schwann cell survival and axon growth after
spinal cord injury. Exp Neurol. 248:170–182, 2013. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Caroleo MC, Costa N, Bracci-Laudiero L and
Aloe L: Human monocyte/macrophages activate by exposure to LPS
overexpress NGF and NGF receptors. J Neuroimmunol. 113:193–201.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang CR, Zhang XY, Liu Y, Du JY, Liang R,
Yu M, Zhang FQ, Mu XF, Li F, Zhou L, et al: Antidepressant drugs
correct the imbalance between proBDNF/p75NTR/Sortilin and mature
BDNF/TrkB in the brain of mice with chronic stress. Neurotox Res.
37:171–182. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ohira K and Hayashi M: A new aspect of the
TrkB signaling pathway in neural plasticity. Curr Neuropharmacol.
7:276–285. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Cao T, Matyas JJ, Renn CL, Faden AI,
Dorsey SG and Wu J: Function and mechanisms of truncated BDNF
receptor TrkB.T1 in neuropathic pain. Cells. 9(1194)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Matusica D, Skeldal S, Sykes AM, Palstra
N, Sharma A and Coulson EJ: An intracellular domain fragment of the
p75 neurotrophin receptor (p75(NTR)) enhances tropomyosin receptor
kinase A (TrkA) receptor function. J Biol Chem. 288:11144–11154.
2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Burnouf T, Kuo YP, Blum D, Burnouf S and
Su CY: Human platelet concentrates: A source of
solvent/detergent-treated highly enriched brain-derived
neurotrophic factor. Transfusion. 52:1721–1728. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Schulte-Herbrüggen O, Nassenstein C,
Lommatzsch M, Quarcoo D, Renz H and Braun A: Tumor necrosis
factor-alpha and interleukin-6 regulate secretion of brain-derived
neurotrophic factor in human monocytes. J Neuroimmunol.
160:204–209. 2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
De Santi L, Cantalupo L, Tassi M,
Raspadori D, Cioni C and Annunziata P: Higher expression of BDNF
receptor gp145trkB is associated with lower apoptosis intensity in
T cell lines in multiple sclerosis. J Neurol Sci. 277:65–70.
2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Schuhmann B, Dietrich A, Sel S, Hahn C,
Klingenspor M, Lommatzsch M, Gudermann T, Braun A, Renz H and
Nockher WA: A role for brain-derived neurotrophic factor in B cell
development. J Neuroimmunol. 163:15–23. 2005.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Garcia-Suarez O, Blanco-Gelaz MA, Lopez
ML, Germana A, Cabo R, Díaz-Esnal B, Silos-Santiago I, Ciriaco E
and Vega JA: Massive lymphocyte apoptosis in the thymus of
functionally deficient TrkB mice. J Neuroimmunol. 129:25–34.
2002.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Maroder M, Bellavia D, Vacca A, Felli MP
and Screpanti I: The thymus at the crossroad of neuroimmune
interactions. Ann N Y Acad Sci. 917:741–747. 2000.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Linker R, Gold R and Luhder F: Function of
neurotrophic factors beyond the nervous system: Inflammation and
autoimmune demyelination. Crit Rev Immunol. 29:43–68.
2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Vega JA, García-Suárez O, Hannestad J,
Pérez-Pérez M and Germanà A: Neurotrophins and the immune system. J
Anat. 203:1–19. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Nockher WA and Renz H: Neurotrophins in
inflammatory lung diseases: Modulators of cell differentiation and
neuroimmune interactions. Cytokine Growth Factor Rev. 14:559–578.
2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Stadelmann C, Kerschensteiner M, Misgeld
T, Brück W, Hohlfeld R and Lassmann H: BDNF and gp145trkB in
multiple sclerosis brain lesions: Neuroprotective interactions
between immune and neuronal cells? Brain. 125:75–85.
2002.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tabakman R, Lecht S, Sephanova S,
Arien-Zakay H and Lazarovici P: Interactions between the cells of
the immune and nervous system: Neurotrophins as neuroprotection
mediators in CNS injury. Prog Brain Res. 146:387–401.
2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Frota ER, Rodrigues DH, Donadi EA, Brum
DG, Maciel DR and Teixeira AL: Increased plasma levels of brain
derived neurotrophic factor (BDNF) after multiple sclerosis
relapse. Neurosci Lett. 460:130–132. 2009.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Linker RA, Lee DH, Demir S, Wiese S, Kruse
N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Lühder F and
Gold R: Functional role of brain-derived neurotrophic factor in
neuroprotective autoimmunity: Therapeutic implications in a model
of multiple sclerosis. Brain. 133:2248–2263. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Steinkamp M, Schulte N, Spaniol U, Pflüger
C, Hartmann C, Kirsch J and von Boyen GB: Brain derived
neurotrophic factor inhibits apoptosis in enteric glia during gut
inflammation. Med Sci Monit. 18:BR117–BR122. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Steinkamp M, Gundel H, Schulte N, Spaniol
U, Pflueger C, Zizer E and von Boyen GB: GDNF protects enteric glia
from apoptosis: Evidence for an autocrine loop. BMC Gastroenterol.
12(6)2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Meir M, Flemming S, Burkard N, Wagner J,
Germer CT and Schlegel N: The glial cell-line derived neurotrophic
factor: A novel regulator of intestinal barrier function in health
and disease. Am J Physiol Gastrointest Liver Physiol.
310:G1118–G1123. 2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Johansson M, Norrgård O and Forsgren S:
Study of expression patterns and levels of neurotrophins and
neurotrophin receptors in ulcerative colitis. Inflamm Bowel Dis.
13:398–409. 2007.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Ricci A, Mariotta S, Saltini C, Falasca C,
Giovagnoli MR, Mannino F, Graziano P, Sciacchitano S and Amenta F:
Neurotrophin system activation in bronchoalveolar lavage fluid
immune cells in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse
Lung Dis. 22:186–194. 2005.PubMed/NCBI
|
|
46
|
Dagnell C, Grunewald J, Kramar M,
Haugom-Olsen H, Elmberger GP, Eklund A and Olgart Höglund C:
Neurotrophins and neurotrophin receptors in pulmonary
sarcoidosis-granulomas as a source of expression. Respir Res.
11(156)2012.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lise MC, Sparsa A, Marie I, Lalloué F, Ly
K, Martel C, Bezanahary H, Gondran G, Loustaud-Ratti V, Bonnetblanc
JM, et al: Serum neurotrophin profile in systemic sclerosis. PLoS
One. 5(e13918)2010.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Donovan MJ, Lin MI, Wiegn P, Ringstedt T,
Kraemer R, Hahn R, Wang S, Ibañez CF, Rafii S and Hempstead BL:
Brain derived neurotrophic factor is an endothelial cell survival
factor required for intramyocardial vessel stabilization.
Development. 127:4531–4540. 2000.PubMed/NCBI
|
|
49
|
Fauchais AL, Boumediene A, Lalloue F,
Gondran G, Loustaud-Ratti V, Vidal E and Jauberteau MO:
Brain-derived neurotrophic factor and nerve growth factor correlate
with T-cell activation in primary Sjogren's syndrome. Scand J
Rheumatol. 38:50–57. 2009.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Li YJ, Yang CS, Lei L, Wu KF, Yang PT and
Xiao WG: Serum nerve grow factor and brain-derived neurotrophic
factor profiles in Sjögren's syndrome concomitant with interstitial
lung disease. Clin Rheumatol. 33:1161–1164. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Grimsholm O, Rantapää-Dahlqvist S, Dalén T
and Forsgren S: BDNF in RA: Downregulated in plasma following
anti-TNF treatment but no correlation with inflammatory parameters.
Clin Rheumatol. 27:1289–1297. 2008.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Rihl M, Kruithof E, Barthel C, De Keyser
F, Veys EM, Zeidler H, Yu DT, Kuipers JG and Baeten D: Involvement
of neurotrophins and their receptors in spondyloarthritis
synovitis: Relation to inflammation and response to treatment. Ann
Rheum Dis. 64:1542–1549. 2005.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Barthel C, Yeremenko N, Jacobs R, Schmidt
RE, Bernateck M, Zeidler H, Tak PP, Baeten D and Rihl M: Nerve
growth factor and receptor expression in rheumatoid arthritis and
spondyloarthritis. Arthritis Res Ther. 11(R82)2009.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ikenouchi-Sugita A, Yoshimura R, Okamoto
T, Umene-Nakano W, Ueda N, Hori H, Katsuki A, Saito K, Tanaka Y and
Nakamura J: Serum brain-derived neurotrophic factor levels as a
novel biological marker for the activities of psychiatric symptoms
in systemic lupus erythematosus. World J Biol Psychiatry.
11:121–128. 2010.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Tamashiro LF, Oliveira RD, Oliveira R,
Frota ER, Donadi EA, Del-Ben CM, Teixeira AL and Louzada-Junior P:
Participation of the neutrophin brain-derived neurotrophic factor
in neuropsychiatric systemic lupus erythematosus. Rheumatology
(Oxford). 53:2182–2190. 2014.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Ikenouchi A, Yoshimura R, Ikemura N,
Utsunomiya K, Mitoma M and Nakamura J: Plasma levels of brain
derived-neurotrophic factor and catecholamine metabolites are
increased during active phase of psychotic symptoms in CNS lupus: A
case report. Prog Neuropsychopharmacol Biol Psychiatry.
30:1359–1363. 2006.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ikenouchi-Sugita A, Yoshimura R, Ueda N,
Kodama Y, Umene-Nakano W and Nakamura J: Continuous decrease in
serum brain-derived neurotrophic factor (BDNF) levels in a
neuropsychiatric syndrome of systemic lupus erythematosus patient
with organic brain changes. Neuropsychiatr Dis Treat. 4:1277–1281.
2008.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Fauchais AL, Lise MC, Marget P, Lapeybie
FX, Bezanahary H, Martel C, Dumonteil S, Sparsa A, Lalloué F, Ly K,
et al: Serum and lymphocytic neurotrophins profiles in systemic
lupus erythematosus: A case-control study. PLoS One.
8(e79414)2013.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zheng Q, Xu MJ, Cheng J, Chen JM, Zheng L
and Li ZG: Serum levels of brain-derived neurotrophic factor are
associated with depressive symptoms in patients with systemic lupus
erythematosus. Psychoneuroendocrinology. 78:246–252.
2017.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Zuccato C, Marullo M, Vitali B, Tarditi A,
Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, et
al: Brain-derived neurotrophic factor in patients with Huntington's
disease. PLoS One. 6(e22966)2011.PubMed/NCBI View Article : Google Scholar
|
